| Year |
Citation |
Score |
| 2008 |
Rakus JF, Fedorov AA, Fedorov EV, Glasner ME, Hubbard BK, Delli JD, Babbitt PC, Almo SC, Gerlt JA. Evolution of enzymatic activities in the enolase superfamily: L-rhamnonate dehydratase Biochemistry. 47: 9944-9954. PMID 18754693 DOI: 10.1021/Bi800914R |
0.588 |
|
| 2002 |
Pootoolal J, Thomas MG, Marshall CG, Neu JM, Hubbard BK, Walsh CT, Wright GD. Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. Proceedings of the National Academy of Sciences of the United States of America. 99: 8962-7. PMID 12060705 DOI: 10.1073/Pnas.102285099 |
0.364 |
|
| 2002 |
Chen H, Hubbard BK, O'Connor SE, Walsh CT. Formation of beta-hydroxy histidine in the biosynthesis of nikkomycin antibiotics. Chemistry & Biology. 9: 103-12. PMID 11841943 DOI: 10.1016/S1074-5521(02)00090-X |
0.491 |
|
| 2001 |
Chen H, Tseng CC, Hubbard BK, Walsh CT. Glycopeptide antibiotic biosynthesis: enzymatic assembly of the dedicated amino acid monomer (S)-3,5-dihydroxyphenylglycine. Proceedings of the National Academy of Sciences of the United States of America. 98: 14901-6. PMID 11752437 DOI: 10.1073/Pnas.221582098 |
0.405 |
|
| 2001 |
Schmidt DMZ, Hubbard BK, Gerlt JA. Evolution of enzymatic activities in the enolase superfamily: Functional assignment of unknown proteins in bacillus subtilis and Escherichia coli as L-Ala-D/L-Glu epimerases Biochemistry. 40: 15707-15715. PMID 11747447 DOI: 10.1021/Bi011640X |
0.675 |
|
| 2001 |
Walsh CT, Chen H, Keating TA, Hubbard BK, Losey HC, Luo L, Marshall CG, Miller DA, Patel HM. Tailoring enzymes that modify nonribosomal peptides during and after chain elongation on NRPS assembly lines. Current Opinion in Chemical Biology. 5: 525-34. PMID 11578925 DOI: 10.1016/S1367-5931(00)00235-0 |
0.304 |
|
| 2001 |
Chen H, Thomas MG, O'Connor SE, Hubbard BK, Burkart MD, Walsh CT. Aminoacyl-S-enzyme intermediates in beta-hydroxylations and alpha,beta-desaturations of amino acids in peptide antibiotics. Biochemistry. 40: 11651-9. PMID 11570865 DOI: 10.1021/Bi0115434 |
0.397 |
|
| 2001 |
Gulick AM, Hubbard BK, Gerlt JA, Rayment I. Evolution of enzymatic activities in the enolase superfamily: identification of the general acid catalyst in the active site of D-glucarate dehydratase from Escherichia coli. Biochemistry. 40: 10054-62. PMID 11513584 DOI: 10.1021/Bi010733B |
0.642 |
|
| 2001 |
Chiu HT, Hubbard BK, Shah AN, Eide J, Fredenburg RA, Walsh CT, Khosla C. Molecular cloning and sequence analysis of the complestatin biosynthetic gene cluster. Proceedings of the National Academy of Sciences of the United States of America. 98: 8548-53. PMID 11447274 DOI: 10.1073/Pnas.151246498 |
0.352 |
|
| 2000 |
Hubbard BK, Thomas MG, Walsh CT. Biosynthesis of L-p-hydroxyphenylglycine, a non-proteinogenic amino acid constituent of peptide antibiotics. Chemistry & Biology. 7: 931-42. PMID 11137816 DOI: 10.1016/S1074-5521(00)00043-0 |
0.38 |
|
| 2000 |
Chen H, Thomas MG, Hubbard BK, Losey HC, Walsh CT, Burkart MD. Deoxysugars in glycopeptide antibiotics: enzymatic synthesis of TDP-L-epivancosamine in chloroeremomycin biosynthesis. Proceedings of the National Academy of Sciences of the United States of America. 97: 11942-7. PMID 11035791 DOI: 10.1073/Pnas.210395097 |
0.475 |
|
| 2000 |
Gulick AM, Hubbard BK, Gerlt JA, Rayment I. Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. Biochemistry. 39: 4590-602. PMID 10769114 DOI: 10.1021/Bi992782I |
0.671 |
|
| 1998 |
Hubbard BK, Koch M, Palmer DR, Babbitt PC, Gerlt JA. Evolution of enzymatic activities in the enolase superfamily: characterization of the (D)-glucarate/galactarate catabolic pathway in Escherichia coli. Biochemistry. 37: 14369-75. PMID 9772162 DOI: 10.1021/Bi981124F |
0.6 |
|
| 1998 |
Palmer DR, Hubbard BK, Gerlt JA. Evolution of enzymatic activities in the enolase superfamily: partitioning of reactive intermediates by (D)-glucarate dehydratase from Pseudomonas putida. Biochemistry. 37: 14350-7. PMID 9772160 DOI: 10.1021/Bi981122V |
0.645 |
|
| 1997 |
Palmer DRJ, Wieczorek SJ, Hubbard BK, Mrachko GT, Gerlt JA. Importance of mechanistic imperatives in enzyme-catalyzed β-elimination reactions: Stereochemical consequences of the dehydration reactions catalyzed by D-galactonate dehydratase from Escherichia coli and D-glucarate dehydratase from Pseudomonas putida Journal of the American Chemical Society. 119: 9580-9581. DOI: 10.1021/Ja970977C |
0.589 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2003 |
Hubbard BK, Walsh CT. Vancomycin assembly: nature's way. Angewandte Chemie (International Ed. in English). 42: 730-65. PMID 12596194 DOI: 10.1002/Anie.200390202 |
0.289 |
|
| 2009 |
Kaushik VK, Kavana M, Volz JM, Weldon SC, Hanrahan S, Xu J, Caplan SL, Hubbard BK. Characterization of recombinant human acetyl-CoA carboxylase-2 steady-state kinetics. Biochimica Et Biophysica Acta. 1794: 961-7. PMID 19236960 DOI: 10.1016/j.bbapap.2009.02.004 |
0.262 |
|
| 2011 |
Castro-Perez JM, Roddy TP, Shah V, Wang SP, Ouyang X, Ogawa A, McLaren DG, Tadin-Strapps M, Robinson MJ, Bartz SR, Ason B, Chen Y, Previs SF, Wong KK, Vreeken RJ, ... ... Hubbard BK, et al. Attenuation of Slc27a5 gene expression followed by LC-MS measurement of bile acid reconjugation using metabolomics and a stable isotope tracer strategy. Journal of Proteome Research. 10: 4683-91. PMID 21819150 DOI: 10.1021/Pr200475G |
0.224 |
|
| 2003 |
Hubbard BK, Walsh CT. Der Aufbau von Vancomycin: so macht es die Natur Angewandte Chemie. 115: 752-789. DOI: 10.1002/Ange.200390171 |
0.222 |
|
| 2011 |
Ni YG, Di Marco S, Condra JH, Peterson LB, Wang W, Wang F, Pandit S, Hammond HA, Rosa R, Cummings RT, Wood DD, Liu X, Bottomley MJ, Shen X, Cubbon RM, ... ... Hubbard B, et al. A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo. Journal of Lipid Research. 52: 78-86. PMID 20959675 DOI: 10.1194/jlr.M011445 |
0.207 |
|
| 2011 |
Lo Surdo P, Bottomley MJ, Calzetta A, Settembre EC, Cirillo A, Pandit S, Ni YG, Hubbard B, Sitlani A, Carfí A. Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH. Embo Reports. 12: 1300-5. PMID 22081141 DOI: 10.1038/embor.2011.205 |
0.17 |
|
| 2010 |
Ni YG, Condra JH, Orsatti L, Shen X, Di Marco S, Pandit S, Bottomley MJ, Ruggeri L, Cummings RT, Cubbon RM, Santoro JC, Ehrhardt A, Lewis D, Fisher TS, Ha S, ... ... Hubbard B, et al. A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake. The Journal of Biological Chemistry. 285: 12882-91. PMID 20172854 DOI: 10.1074/jbc.M110.113035 |
0.165 |
|
| 2013 |
Strack AM, Carballo-Jane E, Wang SP, Xue J, Ping X, McNamara LA, Thankappan A, Price O, Wolff M, Wu TJ, Kawka D, Mariano M, Burton C, Chang CH, Chen J, ... ... Hubbard B, et al. Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis. Journal of Lipid Research. 54: 177-88. PMID 23103473 DOI: 10.1194/jlr.M031344 |
0.164 |
|
| 2006 |
Blackburn C, Guan B, Brown J, Cullis C, Condon SM, Jenkins TJ, Peluso S, Ye Y, Gimeno RE, Punreddy S, Sun Y, Wu H, Hubbard B, Kaushik V, Tummino P, et al. Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4. Bioorganic & Medicinal Chemistry Letters. 16: 3504-9. PMID 16644217 DOI: 10.1016/j.bmcl.2006.03.102 |
0.164 |
|
| 2016 |
Garvie CW, Fraley CV, Elowe NH, Culyba EK, Lemke CT, Hubbard BK, Kaushik VK, Daniels DS. Point mutations at the catalytic site of PCSK9 inhibit folding, autoprocessing and interaction with the LDL receptor. Protein Science : a Publication of the Protein Society. PMID 27534510 DOI: 10.1002/Pro.3019 |
0.162 |
|
| 2011 |
Herath K, Bhat G, Miller PL, Wang SP, Kulick A, Andrews-Kelly G, Johnson C, Rohm RJ, Lassman ME, Previs SF, Johns DG, Hubbard BK, Roddy TP. Equilibration of (2)H labeling between body water and free amino acids: enabling studies of proteome synthesis. Analytical Biochemistry. 415: 197-9. PMID 21596013 DOI: 10.1016/J.Ab.2011.04.031 |
0.157 |
|
| 2010 |
Carballo-Jane E, Chen Z, O'Neill E, Wang J, Burton C, Chang CH, Chen X, Eveland S, Frantz-Wattley B, Gagen K, Hubbard B, Ichetovkin M, Luell S, Meurer R, Song X, et al. ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose. Bioorganic & Medicinal Chemistry. 18: 8669-78. PMID 21115285 DOI: 10.1016/j.bmc.2010.09.074 |
0.156 |
|
| 2015 |
Clifton MC, Dranow DM, Leed A, Fulroth B, Fairman JW, Abendroth J, Atkins KA, Wallace E, Fan D, Xu G, Ni ZJ, Daniels D, Van Drie J, Wei G, Burgin AB, ... ... Hubbard BK, et al. A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1. Plos One. 10: e0125010. PMID 25909780 DOI: 10.1371/Journal.Pone.0125010 |
0.15 |
|
| 2014 |
Singaraja RR, Tietjen I, Hovingh GK, Franchini PL, Radomski C, Wong K, vanHeek M, Stylianou IM, Lin L, Wang L, Mitnaul L, Hubbard B, Winther M, Mattice M, Legendre A, et al. Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans. Journal of Lipid Research. 55: 1693-1701. PMID 24891332 DOI: 10.1194/Jlr.M048710 |
0.149 |
|
| 2010 |
Zhang JH, Roddy TP, Ho PI, Horvath CR, Vickers C, Stout S, Hubbard B, Wang YK, Hill WA, Bojanic D. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening. Journal of Biomolecular Screening. 15: 695-702. PMID 20484097 DOI: 10.1177/1087057110370210 |
0.146 |
|
| 2011 |
McLaren DG, He T, Wang SP, Mendoza V, Rosa R, Gagen K, Bhat G, Herath K, Miller PL, Stribling S, Taggart A, Imbriglio J, Liu J, Chen D, Pinto S, ... ... Hubbard BK, et al. The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species. Journal of Lipid Research. 52: 1150-61. PMID 21415123 DOI: 10.1194/Jlr.M011049 |
0.144 |
|
| 2022 |
MacNair CR, Farha MA, Serrano-Wu MH, Lee KK, Hubbard B, Côté JP, Carfrae LA, Tu MM, Gaulin JL, Hunt DK, Hung DT, Brown ED. Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant. Acs Infectious Diseases. 8: 768-777. PMID 35319198 DOI: 10.1021/acsinfecdis.1c00482 |
0.143 |
|
| 2012 |
Conway JP, Johns DG, Wang SP, Walker ND, McAvoy TA, Zhou H, Zhao X, Previs SF, Roddy TP, Hubbard BK, Yates NA, Hendrickson RC. Measuring H(2)(18)O tracer incorporation on a QQQ-MS platform provides a rapid, transferable screening tool for relative protein synthesis. Journal of Proteome Research. 11: 1591-7. PMID 22289114 DOI: 10.1021/pr2007494 |
0.139 |
|
| 2019 |
Petrilli WL, Adam GC, Erdmann RS, Abeywickrema P, Agnani V, Ai X, Baysarowich J, Byrne N, Caldwell JP, Chang W, DiNunzio E, Feng Z, Ford R, Ha S, Huang Y, ... Hubbard B, et al. From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9. Cell Chemical Biology. PMID 31653597 DOI: 10.1016/J.Chembiol.2019.10.002 |
0.137 |
|
| 2013 |
Zhou H, Castro-Perez J, Lassman ME, Thomas T, Li W, McLaughlin T, Dan X, Jumes P, Wagner JA, Gutstein DE, Hubbard BK, Rader DJ, Millar JS, Ginsberg HN, Reyes-Soffer G, et al. Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 27: 1294-302. PMID 23681806 DOI: 10.1002/Rcm.6572 |
0.136 |
|
| 2006 |
Hubbard B, Doege H, Punreddy S, Wu H, Huang X, Kaushik VK, Mozell RL, Byrnes JJ, Stricker-Krongrad A, Chou CJ, Tartaglia LA, Lodish HF, Stahl A, Gimeno RE. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity. Gastroenterology. 130: 1259-69. PMID 16618417 DOI: 10.1053/J.Gastro.2006.02.012 |
0.135 |
|
| 2010 |
Ranalletta M, Bierilo KK, Chen Y, Milot D, Chen Q, Tung E, Houde C, Elowe NH, Garcia-Calvo M, Porter G, Eveland S, Frantz-Wattley B, Kavana M, Addona G, Sinclair P, ... ... Hubbard B, et al. Biochemical characterization of cholesteryl ester transfer protein inhibitors. Journal of Lipid Research. 51: 2739-52. PMID 20458119 DOI: 10.1194/jlr.M007468 |
0.127 |
|
| 2012 |
Jensen KK, Previs SF, Zhu L, Herath K, Wang SP, Bhat G, Hu G, Miller PL, McLaren DG, Shin MK, Vogt TF, Wang L, Wong KK, Roddy TP, Johns DG, ... Hubbard BK, et al. Demonstration of diet-induced decoupling of fatty acid and cholesterol synthesis by combining gene expression array and 2H2O quantification. American Journal of Physiology. Endocrinology and Metabolism. 302: E209-17. PMID 22045313 DOI: 10.1152/Ajpendo.00436.2011 |
0.122 |
|
| 2018 |
Fang C, Lee KK, Nietupski R, Bates RH, Fernandez-Menendez R, Lopez-Roman EM, Guijarro-Lopez L, Yin Y, Peng Z, Gomez JE, Fisher S, Barros-Aguirre D, Hubbard BK, Serrano-Wu MH, Hung DT. Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 30316633 DOI: 10.1016/J.Bmcl.2018.09.037 |
0.112 |
|
| 2014 |
Sun S, Zhang Z, Kodumuru V, Pokrovskaia N, Fonarev J, Jia Q, Leung PY, Tran J, Ratkay LG, McLaren DG, Radomski C, Chowdhury S, Fu J, Hubbard B, Winther MD, et al. Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases. Bioorganic & Medicinal Chemistry Letters. 24: 520-5. PMID 24374272 DOI: 10.1016/j.bmcl.2013.12.036 |
0.112 |
|
| 2014 |
Ahn SC, Hubbard B, Cha DK, Kim BJ. Simultaneous removal of perchlorate and energetic compounds in munitions wastewater by zero-valent iron and perchlorate-respiring bacteria. Journal of Environmental Science and Health. Part a, Toxic/Hazardous Substances & Environmental Engineering. 49: 575-83. PMID 24410688 DOI: 10.1080/10934529.2014.859455 |
0.11 |
|
| 2011 |
Castro-Perez J, Roddy TP, Nibbering NM, Shah V, McLaren DG, Previs S, Attygalle AB, Herath K, Chen Z, Wang SP, Mitnaul L, Hubbard BK, Vreeken RJ, Johns DG, Hankemeier T. Localization of fatty acyl and double bond positions in phosphatidylcholines using a dual stage CID fragmentation coupled with ion mobility mass spectrometry. Journal of the American Society For Mass Spectrometry. 22: 1552-67. PMID 21953258 DOI: 10.1007/S13361-011-0172-2 |
0.106 |
|
| 2012 |
Johns DG, Duffy J, Fisher T, Hubbard BK, Forrest MJ. On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors. Drugs. 72: 491-507. PMID 22356288 DOI: 10.2165/11599310-000000000-00000 |
0.106 |
|
| 2014 |
Fang C, D'Souza B, Thompson CF, Clifton MC, Fairman JW, Fulroth B, Leed A, McCarren P, Wang L, Wang Y, Feau C, Kaushik VK, Palmer M, Wei G, Golub TR, ... Hubbard BK, et al. Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1). Acs Medicinal Chemistry Letters. 5: 1308-12. PMID 25516789 DOI: 10.1021/Ml500388Q |
0.104 |
|
| 2010 |
Liu M, Wu G, Baysarowich J, Kavana M, Addona GH, Bierilo KK, Mudgett JS, Pavlovic G, Sitlani A, Renger JJ, Hubbard BK, Fisher TS, Zerbinatti CV. PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain. Journal of Lipid Research. 51: 2611-8. PMID 20453200 DOI: 10.1194/jlr.M006635 |
0.103 |
|
| 1997 |
Bibeau CT, Hubbard BK, Abelt CJ. A facile dialkyl ether cleavage and rearrangement under mildly basic conditions during the Williamson synthesis with β-cyclodextrin Chemical Communications. 437-438. |
0.097 |
|
| 2011 |
Ason B, Castro-Perez J, Tep S, Stefanni A, Tadin-Strapps M, Roddy T, Hankemeier T, Hubbard B, Sachs AB, Michael Flanagan W, Kuklin NA, Mitnaul LJ. ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5). Lipids. 46: 991-1003. PMID 21826528 DOI: 10.1007/S11745-011-3596-3 |
0.096 |
|
| 2011 |
Previs SF, Mahsut A, Kulick A, Dunn K, Andrews-Kelly G, Johnson C, Bhat G, Herath K, Miller PL, Wang SP, Azer K, Xu J, Johns DG, Hubbard BK, Roddy TP. Quantifying cholesterol synthesis in vivo using (2)H(2)O: enabling back-to-back studies in the same subject. Journal of Lipid Research. 52: 1420-8. PMID 21498887 DOI: 10.1194/Jlr.D014993 |
0.095 |
|
| 2014 |
Herath KB, Zhong W, Yang J, Mahsut A, Rohm RJ, Shah V, Castro-Perez J, Zhou H, Attygalle AB, Kang L, Singh S, Johns DG, Cleary MA, Hubbard BK, Previs SF, et al. Determination of low levels of 2H-labeling using high-resolution mass spectrometry: application in studies of lipid flux and beyond. Rapid Communications in Mass Spectrometry : Rcm. 28: 239-44. PMID 24375874 DOI: 10.1002/Rcm.6776 |
0.092 |
|
| 2002 |
Ghose S, McNerney TM, Hubbard B. pH Transitions in ion-exchange systems: role in the development of a cation-exchange process for a recombinant protein. Biotechnology Progress. 18: 530-7. PMID 12052070 DOI: 10.1021/bp020002i |
0.091 |
|
| 2011 |
Castro-Perez JM, Roddy TP, Shah V, McLaren DG, Wang SP, Jensen K, Vreeken RJ, Hankemeier T, Johns DG, Previs SF, Hubbard BK. Identifying static and kinetic lipid phenotypes by high resolution UPLC-MS: unraveling diet-induced changes in lipid homeostasis by coupling metabolomics and fluxomics. Journal of Proteome Research. 10: 4281-90. PMID 21744776 DOI: 10.1021/pr200480g |
0.09 |
|
| 2012 |
Lee AY, Yates NA, Ichetovkin M, Deyanova E, Southwick K, Fisher TS, Wang W, Loderstedt J, Walker N, Zhou H, Zhao X, Sparrow CP, Hubbard BK, Rader DJ, Sitlani A, et al. Measurement of fractional synthetic rates of multiple protein analytes by triple quadrupole mass spectrometry. Clinical Chemistry. 58: 619-27. PMID 22249652 DOI: 10.1373/Clinchem.2011.172429 |
0.089 |
|
| 2019 |
Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N, Delano K, Da Silva I, Davis J, Gallo C, Gardner M, ... ... Hubbard BK, et al. Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes. Nature. PMID 31217586 DOI: 10.1038/S41586-019-1315-Z |
0.089 |
|
| 2006 |
Ghose S, Allen M, Hubbard B, Brooks C, Cramer SM. Antibody variable region interactions with Protein A: implications for the development of generic purification processes. Biotechnology and Bioengineering. 92: 665-73. PMID 16206278 DOI: 10.1002/bit.20729 |
0.088 |
|
| 2007 |
Ghose S, Hubbard B, Cramer SM. Binding capacity differences for antibodies and Fc-fusion proteins on protein A chromatographic materials. Biotechnology and Bioengineering. 96: 768-79. PMID 16817242 DOI: 10.1002/bit.21044 |
0.088 |
|
| 2011 |
Mahsut A, Wang SP, McLaren DG, Bhat G, Herath K, Miller PL, Hubbard BK, Johns DG, Previs SF, Roddy TP. Headspace analyses of ²H labeling of acetone: enabling studies of fatty acid oxidation in vivo. Analytical Biochemistry. 408: 351-3. PMID 20851092 DOI: 10.1016/J.Ab.2010.09.016 |
0.087 |
|
| 2006 |
Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. Downstream processing of monoclonal antibodies--application of platform approaches. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 848: 28-39. PMID 17046339 DOI: 10.1016/j.jchromb.2006.09.026 |
0.085 |
|
| 2012 |
Lassman ME, McLaughlin TM, Somers EP, Stefanni AC, Chen Z, Murphy BA, Bierilo KK, Flattery AM, Wong KK, Castro-Perez JM, Hubbard BK, Roddy TP. A rapid method for cross-species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 26: 101-8. PMID 22173797 DOI: 10.1002/rcm.5296 |
0.083 |
|
| 2012 |
Zhou H, Li W, Wang SP, Mendoza V, Rosa R, Hubert J, Herath K, McLaughlin T, Rohm RJ, Lassman ME, Wong KK, Johns DG, Previs SF, Hubbard BK, Roddy TP. Quantifying apoprotein synthesis in rodents: coupling LC-MS/MS analyses with the administration of labeled water. Journal of Lipid Research. 53: 1223-31. PMID 22389331 DOI: 10.1194/Jlr.D021295 |
0.082 |
|
| 2012 |
Chen Z, Wang SP, Krsmanovic ML, Castro-Perez J, Gagen K, Mendoza V, Rosa R, Shah V, He T, Stout SJ, Geoghagen NS, Lee SH, McLaren DG, Wang L, Roddy TP, ... ... Hubbard BK, et al. Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters. Metabolism: Clinical and Experimental. 61: 470-81. PMID 22001333 DOI: 10.1016/j.metabol.2011.08.006 |
0.08 |
|
| 2012 |
Shen X, Wang W, Wang L, Houde C, Wu W, Tudor M, Thompson JR, Sisk CM, Hubbard B, Li J. Identification of genes affecting apolipoprotein B secretion following siRNA-mediated gene knockdown in primary human hepatocytes. Atherosclerosis. 222: 154-7. PMID 22398276 DOI: 10.1016/j.atherosclerosis.2012.02.012 |
0.079 |
|
| 2011 |
Castro-Perez J, Briand F, Gagen K, Wang SP, Chen Y, McLaren DG, Shah V, Vreeken RJ, Hankemeier T, Sulpice T, Roddy TP, Hubbard BK, Johns DG. Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters. Journal of Lipid Research. 52: 1965-73. PMID 21841206 DOI: 10.1194/jlr.M016410 |
0.079 |
|
| 2006 |
Ghose S, Hubbard B, Cramer SM. Evaluation and comparison of alternatives to Protein A chromatography Mimetic and hydrophobic charge induction chromatographic stationary phases. Journal of Chromatography. A. 1122: 144-52. PMID 16750212 DOI: 10.1016/j.chroma.2006.04.083 |
0.078 |
|
| 2012 |
Owens AP, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, Williams JC, Hubbard BK, Dutton JA, Wang J, Tobias PS, Curtiss LK, Daugherty A, Kirchhofer D, Luyendyk JP, et al. Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. The Journal of Clinical Investigation. 122: 558-68. PMID 22214850 DOI: 10.1172/Jci58969 |
0.077 |
|
| 2007 |
Roddy TP, Horvath CR, Stout SJ, Kenney KL, Ho PI, Zhang JH, Vickers C, Kaushik V, Hubbard B, Wang YK. Mass spectrometric techniques for label-free high-throughput screening in drug discovery. Analytical Chemistry. 79: 8207-13. PMID 17902631 DOI: 10.1021/ac062421q |
0.077 |
|
| 2010 |
Shah V, Herath K, Previs SF, Hubbard BK, Roddy TP. Headspace analyses of acetone: a rapid method for measuring the 2H-labeling of water. Analytical Biochemistry. 404: 235-7. PMID 20488158 DOI: 10.1016/J.Ab.2010.05.010 |
0.074 |
|
| 2012 |
Zhang L, McCabe T, Condra JH, Ni YG, Peterson LB, Wang W, Strack AM, Wang F, Pandit S, Hammond H, Wood D, Lewis D, Rosa R, Mendoza V, Cumiskey AM, ... ... Hubbard B, et al. An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes. International Journal of Biological Sciences. 8: 310-27. PMID 22355267 DOI: 10.7150/ijbs.3524 |
0.073 |
|
| 2005 |
Ghose S, Hubbard B, Cramer SM. Protein interactions in hydrophobic charge induction chromatography (HCIC). Biotechnology Progress. 21: 498-508. PMID 15801790 DOI: 10.1021/bp049712+ |
0.072 |
|
| 2017 |
Thomas T, Zhou H, Karmally W, Ramakrishnan R, Holleran S, Liu Y, Jumes P, Wagner JA, Hubbard B, Previs SF, Roddy T, Johnson-Levonas AO, Gutstein DE, Marcovina SM, Rader DJ, et al. CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 28729361 DOI: 10.1161/Atvbaha.117.309549 |
0.071 |
|
| 2006 |
Bakhtiarova A, Taslimi P, Elliman SJ, Kosinski PA, Hubbard B, Kavana M, Kemp DM. Resveratrol inhibits firefly luciferase. Biochemical and Biophysical Research Communications. 351: 481-4. PMID 17064666 DOI: 10.1016/j.bbrc.2006.10.057 |
0.07 |
|
| 2011 |
Chen Z, Strack AM, Stefanni AC, Chen Y, Wu W, Pan Y, Urosevic-Price O, Wang L, McLaughlin T, Geoghagen N, Lassman ME, Roddy TP, Wong KK, Hubbard BK, Flattery AM. Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research. Journal of Cardiovascular Translational Research. 4: 373-83. PMID 21394531 DOI: 10.1007/s12265-011-9264-4 |
0.068 |
|
| 2005 |
Ghose S, McNerney TM, Hubbard B. Preparative protein purification on underivatized silica. Biotechnology and Bioengineering. 87: 413-23. PMID 15281115 DOI: 10.1002/bit.20125 |
0.068 |
|
| 1996 |
Hubbard BK, Beilstein LA, Heath CE, Abelt CJ. Synthesis and characterization of dicyanoanthracene-tethered β-cyclodextrins Journal of the Chemical Society. Perkin Transactions 2. 5: 1005-1009. |
0.066 |
|
| 2012 |
Tep S, Mihaila R, Freeman A, Pickering V, Huynh F, Huyhn F, Tadin-Strapps M, Stracks A, Hubbard B, Caldwell J, Flanagan WM, Kuklin NA, Ason B. Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing. Journal of Lipid Research. 53: 859-67. PMID 22355095 DOI: 10.1194/Jlr.M021063 |
0.066 |
|
| 2021 |
Petrilli WL, Adam GC, Erdmann RS, Abeywickrema P, Agnani V, Ai X, Baysarowich J, Byrne N, Caldwell JP, Chang W, DiNunzio E, Feng Z, Ford R, Ha S, Huang Y, ... Hubbard B, et al. From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9. Cell Chemical Biology. 28: 243. PMID 33607006 DOI: 10.1016/j.chembiol.2021.01.019 |
0.066 |
|
| 2013 |
Singaraja RR, Sivapalaratnam S, Hovingh K, Dubé MP, Castro-Perez J, Collins HL, Adelman SJ, Riwanto M, Manz J, Hubbard B, Tietjen I, Wong K, Mitnaul LJ, van Heek M, Lin L, et al. The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans. Circulation. Cardiovascular Genetics. 6: 54-62. PMID 23243195 DOI: 10.1161/Circgenetics.111.962613 |
0.066 |
|
| 2011 |
Ason B, Tep S, Davis HR, Xu Y, Tetzloff G, Galinski B, Soriano F, Dubinina N, Zhu L, Stefanni A, Wong KK, Tadin-Strapps M, Bartz SR, Hubbard B, Ranalletta M, et al. Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9. Journal of Lipid Research. 52: 679-87. PMID 21262787 DOI: 10.1194/Jlr.M013664 |
0.065 |
|
| 2021 |
Klobucar K, Côté JP, French S, Borrillo L, Guo ABY, Serrano-Wu MH, Lee KK, Hubbard B, Johnson JW, Gaulin JL, Magolan J, Hung DT, Brown ED. Chemical Screen for Vancomycin Antagonism Uncovers Probes of the Gram-Negative Outer Membrane. Acs Chemical Biology. PMID 33974796 DOI: 10.1021/acschembio.1c00179 |
0.065 |
|
| 2012 |
Serrano-Wu MH, Coppola GM, Gong Y, Neubert AD, Chatelain R, Clairmont KB, Commerford R, Cosker T, Daniels T, Hou Y, Jain M, Juedes M, Li L, Mullarkey T, Rocheford E, ... ... Hubbard BK, et al. Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides. Acs Medicinal Chemistry Letters. 3: 411-5. PMID 24900485 DOI: 10.1021/ml3000512 |
0.064 |
|
| 2015 |
Imbriglio JE, Shen DM, Liang R, Marby K, You M, Youm HW, Feng Z, London C, Xiong Y, Tata J, Verras A, Garcia-Calvo M, Song X, Addona G, McLaren DG, ... ... Hubbard B, et al. The Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 (DGAT2) Inhibitors. Journal of Medicinal Chemistry. PMID 26561979 DOI: 10.1021/acs.jmedchem.5b01345 |
0.064 |
|
| 2015 |
Previs SF, Herath K, Castro-Perez J, Mahsut A, Zhou H, McLaren DG, Shah V, Rohm RJ, Stout SJ, Zhong W, Wang SP, Johns DG, Hubbard BK, Cleary MA, Roddy TP. Effect of Error Propagation in Stable Isotope Tracer Studies: An Approach for Estimating Impact on Apparent Biochemical Flux. Methods in Enzymology. 561: 331-58. PMID 26358910 DOI: 10.1016/Bs.Mie.2015.06.021 |
0.062 |
|
| 2004 |
Ghose S, Nagrath D, Hubbard B, Brooks C, Cramer SM. Use and optimization of a dual-flowrate loading strategy to maximize throughput in protein-a affinity chromatography. Biotechnology Progress. 20: 830-40. PMID 15176889 DOI: 10.1021/Bp0342654 |
0.06 |
|
| 2014 |
Sun S, Zhang Z, Raina V, Pokrovskaia N, Hou D, Namdari R, Khakh K, Ratkay LG, McLaren DG, Mork M, Fu J, Ferreira S, Hubbard B, Winther MD, Dales N. Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects. Bioorganic & Medicinal Chemistry Letters. 24: 526-31. PMID 24370012 DOI: 10.1016/j.bmcl.2013.12.035 |
0.059 |
|
| 2009 |
Yen CL, Cheong ML, Grueter C, Zhou P, Moriwaki J, Wong JS, Hubbard B, Marmor S, Farese RV. Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding. Nature Medicine. 15: 442-6. PMID 19287392 DOI: 10.1038/nm.1937 |
0.056 |
|
| 2011 |
Puig O, Yuan J, Stepaniants S, Zieba R, Zycband E, Morris M, Coulter S, Yu X, Menke J, Woods J, Chen F, Ramey DR, He X, O'Neill EA, Hailman E, ... ... Hubbard BK, et al. A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status. Circulation. Cardiovascular Genetics. 4: 595-604. PMID 22010137 DOI: 10.1161/CIRCGENETICS.111.960773 |
0.056 |
|
| 2011 |
Chen Z, Chu D, Castro-Perez JM, Ni W, Zhang A, Krsmanovic ML, Xie D, Shah V, Stout SJ, McLaren DG, Stefanni AC, Lee SH, Roddy TP, Plump AS, Hubbard BK, et al. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice. Journal of Cardiovascular Translational Research. 4: 801-10. PMID 21822774 DOI: 10.1007/s12265-011-9309-8 |
0.055 |
|
| 2015 |
Ozcan L, Xu X, Deng SX, Ghorphade DS, Thomas T, Cremers S, Hubbard B, Serrano-Wu MH, Gaestel M, Landry DW, Tabas I. Treatment of Obese Insulin-Resistant Mice with an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity. Diabetes. PMID 26068544 DOI: 10.2337/Db14-1945 |
0.054 |
|
| 2014 |
Hubbard B, Lockhart G, Gelting RJ, Bertrand F. Development of Haiti's rural water, sanitation and hygiene workforce. Journal of Water, Sanitation, and Hygiene For Development : a Journal of the International Water Association. 4: 159-163. PMID 31798827 DOI: 10.2166/washdev.2013.089 |
0.053 |
|
| 2021 |
Ozcan L, Kasikara C, Yurdagul A, Kuriakose G, Hubbard B, Serrano-Wu MH, Tabas I. Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis. Plos One. 16: e0246600. PMID 33983975 DOI: 10.1371/journal.pone.0246600 |
0.052 |
|
| 2012 |
Chen Z, O'Neill EA, Meurer RD, Gagen K, Luell S, Wang SP, Ichetovkin M, Frantz-Wattley B, Eveland S, Strack AM, Fisher TS, Johns DG, Sparrow CP, Wright SD, Hubbard BK, et al. Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice. Journal of Cardiovascular Pharmacology and Therapeutics. 17: 315-23. PMID 22067613 DOI: 10.1177/1074248411426144 |
0.052 |
|
| 2010 |
Yvan-Charvet L, Kling J, Pagler T, Li H, Hubbard B, Fisher T, Sparrow CP, Taggart AK, Tall AR. Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1430-8. PMID 20448206 DOI: 10.1161/ATVBAHA.110.207142 |
0.052 |
|
| 2019 |
Hubbard B, Roush D. Emerging Unit Operations (Session III): Hydroxyapatite, Mixed-Mode, and Adsorptive Membrane Chromatography; UV-C Inactivation; Chemical Precipitation. Pda Journal of Pharmaceutical Science and Technology. 68: 51-65. PMID 24504236 DOI: 10.5731/pdajpst.2014.00966 |
0.051 |
|
| 2012 |
Han S, Flattery AM, McLaren D, Raubertas R, Lee SH, Mendoza V, Rosa R, Geoghagen N, Castro-Perez JM, Roddy TP, Forrest G, Johns D, Hubbard BK, Li J. Comparison of lipoprotein separation and lipid analysis methodologies for human and cynomolgus monkey plasma samples. Journal of Cardiovascular Translational Research. 5: 75-83. PMID 22194019 DOI: 10.1007/s12265-011-9340-9 |
0.051 |
|
| 2011 |
Castro-Perez J, Previs SF, McLaren DG, Shah V, Herath K, Bhat G, Johns DG, Wang SP, Mitnaul L, Jensen K, Vreeken R, Hankemeier T, Roddy TP, Hubbard BK. In vivo D2O labeling to quantify static and dynamic changes in cholesterol and cholesterol esters by high resolution LC/MS. Journal of Lipid Research. 52: 159-69. PMID 20884843 DOI: 10.1194/Jlr.D009787 |
0.05 |
|
| 2010 |
Koliwad SK, Streeper RS, Monetti M, Cornelissen I, Chan L, Terayama K, Naylor S, Rao M, Hubbard B, Farese RV. DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. The Journal of Clinical Investigation. 120: 756-67. PMID 20124729 DOI: 10.1172/JCI36066 |
0.047 |
|
| 2017 |
Nakajima K, Chatelain R, Clairmont KB, Commerford R, Coppola GM, Daniels T, Forster CJ, Gilmore TA, Gong Y, Jain M, Kanter AD, Kwak Y, Li J, Meyers CD, Neubert AD, ... ... Hubbard BK, et al. Discovery of an orally bioavailable benzimidazole diacylglycerol acyltransferase 1 (DGAT1) inhibitor that suppresses body weight gain in diet induced obese dogs and postprandial triglycerides in humans. Journal of Medicinal Chemistry. PMID 28498655 DOI: 10.1021/acs.jmedchem.7b00173 |
0.046 |
|
| 2024 |
Rauh U, Wei G, Serrano-Wu M, Kosmidis G, Kaulfuss S, Siegel F, Thede K, McFarland J, Lemke CT, Werbeck N, Nowak-Reppel K, Pilari S, Menz S, Ocker M, Zhang W, ... ... Hubbard B, et al. BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models. Nature Cancer. PMID 39179926 DOI: 10.1038/s43018-024-00814-0 |
0.043 |
|
| 2011 |
Tadin-Strapps M, Peterson LB, Cumiskey AM, Rosa RL, Mendoza VH, Castro-Perez J, Puig O, Zhang L, Strapps WR, Yendluri S, Andrews L, Pickering V, Rice J, Luo L, Chen Z, ... ... Hubbard BK, et al. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids. Journal of Lipid Research. 52: 1084-97. PMID 21398511 DOI: 10.1194/Jlr.M012872 |
0.042 |
|
| 2013 |
Hubbard B, Gelting R, Del Carmen Portillo M, Williams T, Torres R. Awareness, adoption and implementation of the water safety plan methodology: insights from five Latin American and Caribbean experiences. Journal of Water, Sanitation, and Hygiene For Development : a Journal of the International Water Association. 3: 541-548. PMID 30450189 DOI: 10.2166/washdev.2013.001 |
0.041 |
|
| 2013 |
Han S, Akiyama TE, Previs SF, Herath K, Roddy TP, Jensen KK, Guan HP, Murphy BA, McNamara LA, Shen X, Strapps W, Hubbard BK, Pinto S, Li C, Li J. Effects of small interfering RNA-mediated hepatic glucagon receptor inhibition on lipid metabolism in db/db mice. Journal of Lipid Research. 54: 2615-22. PMID 23828778 DOI: 10.1194/Jlr.M035592 |
0.041 |
|
| 2011 |
McLaren DG, Miller PL, Lassman ME, Castro-Perez JM, Hubbard BK, Roddy TP. An ultraperformance liquid chromatography method for the normal-phase separation of lipids. Analytical Biochemistry. 414: 266-72. PMID 21402047 DOI: 10.1016/j.ab.2011.03.009 |
0.039 |
|
| 2018 |
Hubbard B. Session 1.5: other viral clearance and inactivation approaches (multimodal chromatography, membrane chromatography, chemical precipitation). Pda Journal of Pharmaceutical Science and Technology. 69: 173-82. PMID 25691725 DOI: 10.5731/pdajpst.2015.01041 |
0.038 |
|
| 2020 |
Lockhart G, Oswald WE, Hubbard B, Medlin E, Gelting RJ. Development of indicators for measuring outcomes of water safety plans. Journal of Water, Sanitation, and Hygiene For Development : a Journal of the International Water Association. 4: 171-181. PMID 26361540 DOI: 10.2166/washdev.2013.159 |
0.038 |
|
| 2007 |
Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, Stevens RD, Bain JR, Newgard CB, Farese RV, Hevener AL, Farese RV. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metabolism. 6: 69-78. PMID 17618857 DOI: 10.1016/J.Cmet.2007.05.005 |
0.033 |
|
| 2009 |
Orians C, Rose S, Hubbard B, Sarisky J, Reason L, Bernichon T, Liebow E, Skarpness B, Buchanan S. Strengthening the capacity of local health agencies through community-based assessment and planning. Public Health Reports (Washington, D.C. : 1974). 124: 875-82. PMID 19894431 DOI: 10.1177/003335490912400616 |
0.031 |
|
| 2012 |
Yin W, Carballo-Jane E, McLaren DG, Mendoza VH, Gagen K, Geoghagen NS, McNamara LA, Gorski JN, Eiermann GJ, Petrov A, Wolff M, Tong X, Wilsie LC, Akiyama TE, Chen J, ... ... Hubbard BK, et al. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. Journal of Lipid Research. 53: 51-65. PMID 22021650 DOI: 10.1194/jlr.M019927 |
0.031 |
|
| 2005 |
Hubbard B, Gelting R, Baffigo V, Sarisky J. Community environmental health assessment strengthens environmental public health services in the Peruvian Amazon. International Journal of Hygiene and Environmental Health. 208: 101-7. PMID 15881983 DOI: 10.1016/j.ijheh.2005.01.010 |
0.029 |
|
| 2024 |
Peer K, Hubbard B, Monti M, Vander Kelen P, Werner AK. The private well water climate impact index: Characterization of community-level climate-related hazards and vulnerability in the continental United States. The Science of the Total Environment. 957: 177409. PMID 39510280 DOI: 10.1016/j.scitotenv.2024.177409 |
0.028 |
|
| 2019 |
Hubbard B. Viral Clearance by Traditional Operations with Significant Knowledge Gaps (Session II): Protein A Chromatography. Pda Journal of Pharmaceutical Science and Technology. 68: 13-6. PMID 24504231 DOI: 10.5731/pdajpst.2014.00961 |
0.027 |
|
| 2012 |
Ai X, Fischer P, Palyha OC, Wisniewski D, Hubbard B, Akinsanya K, Strack AM, Ehrhardt AG. Utilizing HaloTag Technology to Track the Fate of PCSK9 from Intracellular vs. Extracellular Sources. Current Chemical Genomics. 6: 38-47. PMID 23115612 DOI: 10.2174/1875397301206010038 |
0.027 |
|
| 2021 |
Sabogal R, Kalis M, Hubbard B, Oeffinger J, Baddour LJ, Tate C, Shorter C. Innovative Safe Water Program Improvement E-Learning for Environmental Health Professionals. Journal of Environmental Health. 80: 38-40. PMID 32327767 |
0.026 |
|
| 2007 |
Hubbard BK, Enyedy I, Gilmore TA, Serrano-Wu MH. Antisense and small-molecule modulation of diacylglycerol acyltransferase Expert Opinion On Therapeutic Patents. 17: 1331-1339. DOI: 10.1517/13543776.17.11.1331 |
0.021 |
|
| 2023 |
Laco J, Hubbard B, McClenahan S. Tools To Help Conquer The Model Aquatic Health Code. Journal of Environmental Health. 82: 36-38. PMID 37200938 |
0.019 |
|
| 2011 |
Monetti M, Levin MC, Watt MJ, Hubbard BK, Newgard C, Farese RV, Hevener AL, Farese RV. Hepatic acyl-CoA:diacylglcyerol acyltransferase (DGAT) overexpression, diacylglycerol, and insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America. 108: E523; author reply E. PMID 21807991 DOI: 10.1073/Pnas.1108505108 |
0.018 |
|
| 2011 |
Hubbard B, Sarisky J, Gelting R, Baffigo V, Seminario R, Centurion C. A community demand-driven approach toward sustainable water and sanitation infrastructure development. International Journal of Hygiene and Environmental Health. 214: 326-34. PMID 21680241 DOI: 10.1016/j.ijheh.2011.05.005 |
0.013 |
|
| 2021 |
Hunter CM, Salandy SW, Smith JC, Edens C, Hubbard B. Racial Disparities in Incidence of Legionnaires' Disease and Social Determinants of Health: A Narrative Review. Public Health Reports (Washington, D.C. : 1974). 333549211026781. PMID 34185609 DOI: 10.1177/00333549211026781 |
0.012 |
|
| 2007 |
Hubbard B. Working to build healthy communities: community environmental health assessments using PACE EH. Journal of Environmental Health. 69: 32-3. PMID 17066948 |
0.011 |
|
| 2016 |
Sabogal RI, Hubbard B. Improving State and Local Capacity to Assess and Manage Risks Associated With Private Wells and Other Drinking Water Systems Not Covered by the Safe Drinking Water Act. Journal of Environmental Health. 78: 40-2. PMID 26738317 |
0.011 |
|
| 2013 |
Horton LM, Burgess P, Iossifova Y, Brown MJ, Mortensen ME, Yip F, Gelting R, Hubbard B, Kapil V. Children's Environmental Health at CDC. Revista De Salud Ambiental. 13: 5-11. PMID 26339221 |
0.01 |
|
| 2011 |
Chen F, Maridakis V, O'Neill EA, Hubbard BK, Strack A, Beals C, Herman GA, Wong P. The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 16: 321-33. PMID 21417623 DOI: 10.3109/1354750X.2011.561367 |
0.01 |
|
| 2007 |
Hubbard B. Environmental public health leadership revisited. Journal of Environmental Health. 70: 51-2. PMID 17886583 |
0.01 |
|
| Hide low-probability matches. |